IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Trailing returns of the benchmark index
| Sr No | Scheme | Category | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y | Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 |  ICICI Pru Nifty Pharma Index Fu... | Index Fund | ₹22.28 | ₹177.33 Cr | 0.51% | 30.47% | 23.16% | — | Very High |
Nifty Pharma TRI is used as the benchmark for 1 direct growth and open-ended mutual fund schemes across 1 categories.
Mutual funds benchmarked against Nifty Pharma TRI manage total assets worth ₹177.33 Cr.
The 1-year return of Nifty Pharma TRI is 29.42%.
The 3-year annualised return of Nifty Pharma TRI is 23.56%.
ICICI Pru Nifty Pharma Index Fund-Dir (G) is the largest fund benchmarked against Nifty Pharma TRI by fund size, managing ₹177.33 Cr.
